Table 3.
Clinicopathologic characteristics of the patients with PAAD.
| Characteristics | High GLUT1 expression | Low GLUT1 expression | χ2 | P-Value |
|---|---|---|---|---|
| n (%) | n (%) | |||
| Gender | 0.285 | 0.594 | ||
| Male | 32(74.42%) | 11(25.58%) | ||
| Female | 20(83.33%) | 4(16.67%) | ||
| Age | 0.082 | 0.774 | ||
| ≥50 | 42(77.78%) | 12(22.22%) | ||
| <50 | 9(69.23%) | 4(30.77%) | ||
| Tumor size | 4.411 | 0.036* | ||
| ≥3cm | 46(80.70%) | 11(19.30%) | ||
| <3cm | 5(50.00%) | 5(50.00%) | ||
| T stage | 0.225 | 0.635 | ||
| T1-T2 | 8(66.67%) | 4(33.33%) | ||
| T3-T4 | 43(78.18%) | 12(21.82%) | ||
| N-stage | 5.553 | 0.018** | ||
| N0 | 18(62.07%) | 11(37.93%) | ||
| N1 | 33(86.84%) | 5(13.16%) | ||
| M-stage | 1.352 | 0.245 | ||
| M0 | 39(72.22%) | 15(27.78%) | ||
| M1 | 12(92.31%) | 1(7.69%) | ||
| Pathologic stage | 1.055 | 0.304 | ||
| I-II | 36(72.00%) | 14(28.00%) | ||
| III-IV | 15(88.24%) | 2(11.76%) | ||
| Differentiation | 6.013 | 0.049* | ||
| Well | 13(59.09%) | 9(40.91%) | ||
| Moderately | 19(79.17%) | 5(20.83%) | ||
| Poorly | 19(90.48%) | 2(9.52%) |
*P<0.05; **P<0.01.